Jiaping Li
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research
- Infections and bacterial resistance
Papers in
-
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 4
-
- RNA modifications and cancer 3
- RNA Research and Splicing 2
- Co-authors
- Rong Zhang (10 shared papers)Edward Wai‐Chi Chan (3 shared papers)Yi Li (2 shared papers)Sheng Chen (4 shared papers)Hongwei Zhou (4 shared papers)Yīng Fāng (3 shared papers)Kang Liao (1 shared paper)Lizhang Liu (1 shared paper)
- Journals
- Journal of Translational Medicine (2 papers)Microbial Biotechnology (2 papers)Tumor Biology (2 papers)Frontiers in Microbiology (2 papers)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Jiaping Li
31 papers receiving 805 citations
Jiaping Li's Hit Papers
Peers
Comparison fields: 5 of 70
- Molecular Medicine 564
- Endocrinology 218
- Applied Microbiology and Biotechnology 65
- Clinical Biochemistry 167
- Pharmacology 169
Countries citing papers authored by Jiaping Li
This map shows the geographic impact of Jiaping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping Li more than expected).
Fields of papers citing papers by Jiaping Li
This network shows the impact of papers produced by Jiaping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping Li. The network helps show where Jiaping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China Hit paper breakdown → | 2017 | 423 |
| 2 | 2022 | 122 | |
| 3 | 2021 | 33 | |
| 4 | 2020 | 27 | |
| 5 | 2019 | 23 | |
| 6 | 2018 | 20 | |
| 7 | 2015 | 19 | |
| 8 | 2019 | 17 | |
| 9 | 2014 | 17 | |
| 10 | 2023 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2020 | 8 | |
| 15 | 2015 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2024 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE | 2022 | 4 |
About Jiaping Li
Jiaping Li is a scholar working on Cancer Research, Molecular Biology, Clinical Biochemistry, Molecular Medicine and Pathology and Forensic Medicine, having authored 35 papers that have together received 814 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (8 papers), Antibiotic Resistance in Bacteria (7 papers), Cancer-related molecular mechanisms research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers), Cancer Research and Treatments (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Molecular Medicine (564 citations), Endocrinology (218 citations), Applied Microbiology and Biotechnology (65 citations), Clinical Biochemistry (167 citations) and Pharmacology (169 citations). Jiaping Li has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Rong Zhang, Edward Wai‐Chi Chan, Yi Li, Sheng Chen, Hongwei Zhou, Yīng Fāng, Kang Liao, Lizhang Liu, Qiaoling Sun and Jiang Yu. Their work appears in journals such as Journal of Translational Medicine, Microbial Biotechnology, Tumor Biology, Frontiers in Microbiology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.